SBIR/STTR Research Award

Ultra-sensitive Rapid Diagnostic Test to Support the End-Game of the Global Program to Eliminate Lymphatic Filariasis

Award identifier c922aeb4420a7038b31db095e9586aa98245968557411c7f481654d9e7731806Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$224,246

Program and phase

STTR · Phase I

Award year

2019

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
NANOCOMPOSIX, INC.
Proposal award date
2018-12-18
Contract end date
2020-02-17
UEI
EVQMBF7KC8P3
Solicitation number
PA18-575
Topic code
NIAID

Research abstract

Project SummaryAbstract Lymphatic filariasisLFcaused by the parasitic filarial worm Wuchereria bancroftiis a disfiguring and debilitating neglected tropical disease that affectsmillion people incountriesThrough the World Health Organization sWHOGlobal Program for the Elimination of Lymphatic FilariasisGPELFbillion drug regimens have been distributed via mass drug administrationMDAtomillion people to treat the disease and prevent its spreadMany countries are now approaching the elimination pointwhere transmission is permanently interruptedat least in theoryAs per WHO guidelinesthese countries will require ayear surveillance plan to demonstrate that transmission is no longer occurringand to allow for rapid intervention in case of reemergence of the diseaseEffective surveillance strategies will need to be supported by sensitive and specific diagnostic toolsThe only field deployable test recommended by WHO for transmission assessment surveysTASof lymphatic filariasis is the immunochromatography testcardICTAlereAlthough this test has been used fordecades to detect active infectionsit remains suboptimal for surveillance activitiesas it detects an antigen measurable in circulation onlymonths post infection and lacks sensitivity in post MDA settingsdue to low parasite burdenExperts agree that what is required for surveillance is a rapid diagnostic testRDTindicative of early exposure to Wbancrofti infective larvaeLdevelopment stagefor which the best biomarker are IgGantibodies specific to the Wbantigen expressed by LlarvaeHereinwe propose an ultrasensitive RDT for the detection of Wbspecific IgGantibodiesWe have introduced a novel class of plasmonic gold nanoshells to increase the sensitivity of lateral flow immunoassaysand in preliminary experiments have demonstrated their superior performance for detecting a Wbspecific IgGserological responseWe now aim at deliveringadvanced prototypes as sensitive and specific as the reference WbELISAInBiostest used at the CDCBy the end of this Phase I STTR grant these prototypes will be available for field evaluation studiesThis new RDT will ultimately support the end game of the GPELFProject Narrative There is an urgent need for new and sensitive field deployable diagnostics to assist countries in surveilling possible recrudescence of the filarial worm Wuchereria bancroftithe main causative pathogen of lymphatic filariasisLFand the focus of the most ambitious mass drug administrationMDAprograms ever implemented by WHOWe propose an ultrasensitive lateral flow assay to detect early infection through the diagnosis of IgGantibodies generated against the Wbantigenexpressed by the infectiveLstage of WbancroftiThis diagnostic device will be used after MDA campaigns to certify that countries have eliminated LF without the threat of reemergenceas mandated by WHO

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Research funding history

50 SBIR/STTR records share this UEI (2005–2020). Reported award amounts total $19,180,547. Reported amounts are not federal obligations.

Phases: Phase I, Phase II

Agencies: Department of Defense, Department of Health and Human Services, National Science Foundation, National Aeronautics and Space Administration

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.